These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 23340539)
1. A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation. Manchikanti L; Cash KA; Malla Y; Pampati V; Fellows B Pain Physician; 2013 Jan; 16(1):E1-E13. PubMed ID: 23340539 [TBL] [Abstract][Full Text] [Related]
2. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030 [TBL] [Abstract][Full Text] [Related]
5. Opioid epidemic in the United States. Manchikanti L; Helm S; Fellows B; Janata JW; Pampati V; Grider JS; Boswell MV Pain Physician; 2012 Jul; 15(3 Suppl):ES9-38. PubMed ID: 22786464 [TBL] [Abstract][Full Text] [Related]
6. Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC). Sekhon R; Aminjavahery N; Davis CN; Roswarski MJ; Robinette C Pain Med; 2013 Oct; 14(10):1548-56. PubMed ID: 23746149 [TBL] [Abstract][Full Text] [Related]
7. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640 [TBL] [Abstract][Full Text] [Related]
8. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study. Manchikanti L; Damron KS; McManus CD; Barnhill RC Pain Physician; 2004 Oct; 7(4):431-7. PubMed ID: 16858484 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Manchikanti L; Manchikanti KN; Pampati V; Cash KA Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population. Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends. Manchikanti L; Fellows B; Damron KS; Pampati V; McManus CD J Ky Med Assoc; 2005 Feb; 103(2):55-62. PubMed ID: 15751456 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients. Manchikanti L; Malla Y; Wargo BW; Fellows B Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372 [TBL] [Abstract][Full Text] [Related]
13. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972 [TBL] [Abstract][Full Text] [Related]
14. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS). Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473 [TBL] [Abstract][Full Text] [Related]
15. An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners. Holliday S; Magin P; Dunbabin J; Oldmeadow C; Henry JM; Lintzeris N; Attia J; Goode S; Dunlop A Pain Med; 2013 Jan; 14(1):62-74. PubMed ID: 23279722 [TBL] [Abstract][Full Text] [Related]
18. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013 [TBL] [Abstract][Full Text] [Related]
19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Manchikanti L; Singh A Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]